CRANE CO (CR) Stock Fundamental Analysis
USA - NYSE:CR - US2244081046 - Common Stock
179.46 USD
-0.24 (-0.13%)
We assign a fundamental rating of 6 out of 10 to CR. CR was compared to 129 industry peers in the Machinery industry. CR scores excellent points on both the profitability and health parts. This is a solid base for a good stock. CR is valied quite expensively at the moment, while it does show a decent growth rate. With these ratings, CR could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
In the past year CR was profitable.
In the past year CR had a positive cash flow from operations.
Each year in the past 5 years CR has been profitable.
CR had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
CR has a better Return On Assets (13.98%) than 92.25% of its industry peers.
CR has a better Return On Equity (18.65%) than 82.95% of its industry peers.
The Return On Invested Capital of CR (13.83%) is better than 82.95% of its industry peers.
CR had an Average Return On Invested Capital over the past 3 years of 9.11%. This is in line with the industry average of 10.01%.
The 3 year average ROIC (9.11%) for CR is below the current ROIC(13.83%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.98% | ||
| ROE | 18.65% | ||
| ROIC | 13.83% |
ROA(3y)10.39%
ROA(5y)10.5%
ROE(3y)19.31%
ROE(5y)22.01%
ROIC(3y)9.11%
ROIC(5y)8.41%
1.3 Margins
CR's Profit Margin of 16.60% is amongst the best of the industry. CR outperforms 92.25% of its industry peers.
In the last couple of years the Profit Margin of CR has grown nicely.
CR has a better Operating Margin (17.64%) than 82.95% of its industry peers.
In the last couple of years the Operating Margin of CR has grown nicely.
Looking at the Gross Margin, with a value of 42.62%, CR is in the better half of the industry, outperforming 78.29% of the companies in the same industry.
CR's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.64% | ||
| PM (TTM) | 16.6% | ||
| GM | 42.62% |
OM growth 3Y15.82%
OM growth 5Y3.47%
PM growth 3Y-13.15%
PM growth 5Y27.77%
GM growth 3Y6.84%
GM growth 5Y2.54%
2. Health
2.1 Basic Checks
CR has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
CR has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CR has less shares outstanding
The debt/assets ratio for CR has been reduced compared to a year ago.
2.2 Solvency
CR has an Altman-Z score of 12.34. This indicates that CR is financially healthy and has little risk of bankruptcy at the moment.
CR's Altman-Z score of 12.34 is amongst the best of the industry. CR outperforms 93.80% of its industry peers.
CR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.16 | ||
| Altman-Z | 12.34 |
ROIC/WACC1.45
WACC9.53%
2.3 Liquidity
A Current Ratio of 2.93 indicates that CR has no problem at all paying its short term obligations.
CR has a better Current ratio (2.93) than 76.74% of its industry peers.
A Quick Ratio of 1.98 indicates that CR should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.98, CR is in the better half of the industry, outperforming 75.97% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.93 | ||
| Quick Ratio | 1.98 |
3. Growth
3.1 Past
CR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 23.82%, which is quite impressive.
The Earnings Per Share has been decreasing by -3.00% on average over the past years.
Looking at the last year, CR shows a decrease in Revenue. The Revenue has decreased by -4.07% in the last year.
Measured over the past years, CR shows a decrease in Revenue. The Revenue has been decreasing by -8.28% on average per year.
EPS 1Y (TTM)23.82%
EPS 3Y-8.02%
EPS 5Y-3%
EPS Q2Q%13.85%
Revenue 1Y (TTM)-4.07%
Revenue growth 3Y1.09%
Revenue growth 5Y-8.28%
Sales Q2Q%-0.69%
3.2 Future
Based on estimates for the next years, CR will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.28% on average per year.
The Revenue is expected to grow by 8.42% on average over the next years. This is quite good.
EPS Next Y15.19%
EPS Next 2Y13.6%
EPS Next 3Y14.19%
EPS Next 5Y13.28%
Revenue Next Year6.89%
Revenue Next 2Y8.91%
Revenue Next 3Y8.97%
Revenue Next 5Y8.42%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 32.57 indicates a quite expensive valuation of CR.
Based on the Price/Earnings ratio, CR is valued a bit more expensive than the industry average as 63.57% of the companies are valued more cheaply.
CR's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.49.
A Price/Forward Earnings ratio of 26.95 indicates a quite expensive valuation of CR.
CR's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. CR is more expensive than 63.57% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CR to the average of the S&P500 Index (22.99), we can say CR is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.57 | ||
| Fwd PE | 26.95 |
4.2 Price Multiples
68.99% of the companies in the same industry are cheaper than CR, based on the Enterprise Value to EBITDA ratio.
The rest of the industry has a similar Price/Free Cash Flow ratio as CR.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 34.9 | ||
| EV/EBITDA | 23.74 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of CR may justify a higher PE ratio.
CR's earnings are expected to grow with 14.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.14
PEG (5Y)N/A
EPS Next 2Y13.6%
EPS Next 3Y14.19%
5. Dividend
5.1 Amount
CR has a yearly dividend return of 0.50%, which is pretty low.
CR's Dividend Yield is comparable with the industry average which is at 1.81.
With a Dividend Yield of 0.50, CR pays less dividend than the S&P500 average, which is at 2.43.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.5% |
5.2 History
The dividend of CR decreases each year by -12.19%.
CR has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-12.19%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
CR pays out 14.18% of its income as dividend. This is a sustainable payout ratio.
DP14.18%
EPS Next 2Y13.6%
EPS Next 3Y14.19%
NYSE:CR (10/15/2025, 12:48:32 PM)
179.46
-0.24 (-0.13%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners77.38%
Inst Owner Change0%
Ins Owners0.27%
Ins Owner Change-0.15%
Market Cap10.33B
Analysts82.35
Price Target215.01 (19.81%)
Short Float %1.06%
Short Ratio1.78
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.5% |
Yearly Dividend0.82
Dividend Growth(5Y)-12.19%
DP14.18%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.54%
Min EPS beat(2)3.28%
Max EPS beat(2)7.79%
EPS beat(4)4
Avg EPS beat(4)3.22%
Min EPS beat(4)0.24%
Max EPS beat(4)7.79%
EPS beat(8)8
Avg EPS beat(8)5.17%
EPS beat(12)11
Avg EPS beat(12)8.83%
EPS beat(16)15
Avg EPS beat(16)9.67%
Revenue beat(2)0
Avg Revenue beat(2)-1.25%
Min Revenue beat(2)-1.29%
Max Revenue beat(2)-1.2%
Revenue beat(4)0
Avg Revenue beat(4)-1.51%
Min Revenue beat(4)-2.46%
Max Revenue beat(4)-1.07%
Revenue beat(8)2
Avg Revenue beat(8)-0.73%
Revenue beat(12)4
Avg Revenue beat(12)2.9%
Revenue beat(16)6
Avg Revenue beat(16)0.35%
PT rev (1m)0%
PT rev (3m)9.77%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.49%
EPS NY rev (1m)0%
EPS NY rev (3m)4.23%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.03%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.43%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.57 | ||
| Fwd PE | 26.95 | ||
| P/S | 4.87 | ||
| P/FCF | 34.9 | ||
| P/OCF | 29.82 | ||
| P/B | 5.48 | ||
| P/tB | 9.88 | ||
| EV/EBITDA | 23.74 |
EPS(TTM)5.51
EY3.07%
EPS(NY)6.66
Fwd EY3.71%
FCF(TTM)5.14
FCFY2.87%
OCF(TTM)6.02
OCFY3.35%
SpS36.83
BVpS32.78
TBVpS18.16
PEG (NY)2.14
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.98% | ||
| ROE | 18.65% | ||
| ROCE | 17.88% | ||
| ROIC | 13.83% | ||
| ROICexc | 16.44% | ||
| ROICexgc | 31.5% | ||
| OM | 17.64% | ||
| PM (TTM) | 16.6% | ||
| GM | 42.62% | ||
| FCFM | 13.96% |
ROA(3y)10.39%
ROA(5y)10.5%
ROE(3y)19.31%
ROE(5y)22.01%
ROIC(3y)9.11%
ROIC(5y)8.41%
ROICexc(3y)10.78%
ROICexc(5y)10.01%
ROICexgc(3y)18.74%
ROICexgc(5y)19.36%
ROCE(3y)12.01%
ROCE(5y)11.18%
ROICexcg growth 3Y10.29%
ROICexcg growth 5Y0.39%
ROICexc growth 3Y13.04%
ROICexc growth 5Y6.99%
OM growth 3Y15.82%
OM growth 5Y3.47%
PM growth 3Y-13.15%
PM growth 5Y27.77%
GM growth 3Y6.84%
GM growth 5Y2.54%
F-Score7
Asset Turnover0.84
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.16 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 101% | ||
| Cap/Sales | 2.38% | ||
| Interest Coverage | 19.47 | ||
| Cash Conversion | 81.73% | ||
| Profit Quality | 84.11% | ||
| Current Ratio | 2.93 | ||
| Quick Ratio | 1.98 | ||
| Altman-Z | 12.34 |
F-Score7
WACC9.53%
ROIC/WACC1.45
Cap/Depr(3y)93.58%
Cap/Depr(5y)79.88%
Cap/Sales(3y)1.9%
Cap/Sales(5y)1.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.82%
EPS 3Y-8.02%
EPS 5Y-3%
EPS Q2Q%13.85%
EPS Next Y15.19%
EPS Next 2Y13.6%
EPS Next 3Y14.19%
EPS Next 5Y13.28%
Revenue 1Y (TTM)-4.07%
Revenue growth 3Y1.09%
Revenue growth 5Y-8.28%
Sales Q2Q%-0.69%
Revenue Next Year6.89%
Revenue Next 2Y8.91%
Revenue Next 3Y8.97%
Revenue Next 5Y8.42%
EBIT growth 1Y13.55%
EBIT growth 3Y17.08%
EBIT growth 5Y-5.09%
EBIT Next Year26.14%
EBIT Next 3Y18.83%
EBIT Next 5Y14.77%
FCF growth 1Y152.76%
FCF growth 3Y-20.47%
FCF growth 5Y-6.44%
OCF growth 1Y165.56%
OCF growth 3Y-18.53%
OCF growth 5Y-7.3%